Literature DB >> 18566566

False-positive oral fluid rapid HIV tests--New York City, 2005-2008.

.   

Abstract

The New York City Department of Health and Mental Hygiene (NYC DOHMH) operates 10 sexually transmitted disease (STD) walk-in clinics offering various free services, including confidential or anonymous testing for human immunodeficiency virus (HIV). In January 2004, the STD clinics introduced on-site rapid HIV testing of finger-stick whole-blood specimens using the OraQuick(R) brand test (OraSure Technologies, Bethlehem, Pennsylvania). In March 2005, the clinics replaced finger-stick whole-blood testing with oral fluid testing with the OraQuick Advance Rapid HIV-1/2 Antibody Test. The clinics use Western blot confirmatory tests on serum to confirm all whole-blood or oral fluid reactive (i.e., preliminary positive) rapid tests. In late 2005, an unexpected increase in the number of false-positive oral fluid tests occurred, but the increase subsided after several months. In December 2005, while the cluster of false-positive oral fluid test results was being investigated, the NYC DOHMH Bureau of STD Control suspended oral fluid testing in the clinics for 3 weeks and replaced it with finger-stick whole-blood rapid testing, which produced no false-positive test results. On December 21, 2005, NYC DOHMH resumed oral fluid rapid testing but also introduced the use of immediate follow-up finger-stick whole-blood testing, using a second OraQuick test, after any reactive oral fluid test result. In late 2007, another larger increase in the incidence of false-positive oral fluid rapid test results was observed. The cause for the episodic increases in false-positive oral fluid tests has not yet been determined. NYC DOHMH has again suspended the use of oral fluid testing in STD clinics, and finger-stick whole-blood testing is the only rapid HIV test being used in this setting. These findings underscore the importance of confirming all reactive HIV tests, both from oral fluid and whole-blood specimens. In addition, the results suggest that the NYC DOHMH strategy of following up reactive oral fluid test results with an immediate finger-stick whole-blood test reduced the number of apparent false-positive oral fluid test results and might be a useful strategy in other settings and locations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566566

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  21 in total

1.  HIV testing updates and challenges: when regulatory caution and public health imperatives collide.

Authors:  Bernard M Branson
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

2.  Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis.

Authors:  Marco Schito; Trevor F Peter; Sean Cavanaugh; Amy S Piatek; Gloria J Young; Heather Alexander; William Coggin; Gonzalo J Domingo; Dennis Ellenberger; Eugen Ermantraut; Ilesh V Jani; Achilles Katamba; Kara M Palamountain; Shaffiq Essajee; David W Dowdy
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

3.  Marketing the HIV test to MSM: ethnic differences in preferred venues and sources.

Authors:  Julia Lechuga; Jill T Owczarzak; Andrew E Petroll
Journal:  Health Promot Pract       Date:  2012-10-22

4.  Monitoring temporal changes in the specificity of an oral HIV test: a novel application for use in postmarketing surveillance.

Authors:  Joseph R Egger; Kevin J Konty; Jessica M Borrelli; Julia Cummiskey; Susan Blank
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

5.  Ethical and legal issues on HIV testing, policy and the practice of dentistry.

Authors:  Sudeshni Naidoo; Anthony Vernillo
Journal:  J Forensic Odontostomatol       Date:  2012-12-01

6.  Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe.

Authors:  Sophie J S Pascoe; Lisa F Langhaug; James Mudzori; Eileen Burke; Richard Hayes; Frances M Cowan
Journal:  AIDS Patient Care STDS       Date:  2009-07       Impact factor: 5.078

7.  Price, performance, and the FDA approval process: the example of home HIV testing.

Authors:  A David Paltiel; Harold A Pollack
Journal:  Med Decis Making       Date:  2009-05-08       Impact factor: 2.583

8.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men.

Authors:  Joanne D Stekler; Joshua D O'Neal; Aric Lane; Fred Swanson; Janine Maenza; Claire E Stevens; Robert W Coombs; Joan A Dragavon; Paul D Swenson; Matthew R Golden; Bernard M Branson
Journal:  J Clin Virol       Date:  2013-12       Impact factor: 3.168

10.  Another look at Emergency Department HIV screening in practice: no need to revise expectations.

Authors:  Jeremy Brown; Manya Magnus; Maggie Czarnogorski; Vanessa Lee
Journal:  AIDS Res Ther       Date:  2010-01-05       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.